Home > Specialists > General Surgery > Dr. Zhilong Ai (艾志龙)
Specialty & Clinical Focus:
General surgery specialist at Zhongshan Hospital, Fudan University in Shanghai, with a focused practice in thyroid and parathyroid surgery, including thyroid nodules, thyroid cancer, parathyroid disease, and neck masses.
Professional Title & Qualifications:
Chief Physician
Associate Professor
PhD
Master's Supervisor
Hospital & Department：
Shanghai Zhongshan Hospital, Fudan University – Department of General Surgery
(address: No. 180 Fenglin Road, Xuhui District, Shanghai, 200032)
Dr. Zhilong Ai (艾志龙) - Endocrine Surgeon
Personal Biography
Dr. Zhilong Ai is a Chief Physician, Associate Professor, PhD, and Master's Supervisor in the Department of General Surgery at Zhongshan Hospital, Fudan University in Shanghai. He serves as Director of the Surgical Day Ward Department and Deputy Administrative Director of General Surgery. A graduate of the former Shanghai Medical University in Clinical Medicine, Dr. Ai focuses on the diagnosis and surgical management of thyroid nodules, thyroid cancer, parathyroid diseases, and neck masses.
Why Choose Dr. Zhilong Ai for your Care?
Dr. Zhilong Ai combines senior clinical leadership at Zhongshan Hospital, Fudan University with a focused practice in thyroid, parathyroid, and neck-mass surgery. His experience with thyroid nodules, thyroid cancer, and parathyroid disease is supported by national professional committee roles and an active research background, including 10 SCI-indexed publications. For international patients considering specialist care in Shanghai, a remote review of medical records, imaging, and diagnostic reports can help clarify whether the case fits his clinical scope, identify the key questions to address, and prepare a more informed next step before travel.
Pre-Travel Case Review & Specialist Liaison
Before travelling to Shanghai, international patients can request MedBridgeNZ coordination for a remote specialist review with Dr. Zhilong Ai. We organize medical records, coordinate translation where needed, and arrange secure, client-authorized document transfer and appointment communication with Zhongshan Hospital. Once the hospital confirms the review arrangement, Dr. Ai will review the submitted materials, provide a specialist opinion and recommendations, and address the questions submitted with the case.
After the specialist response is received, MedBridgeNZ can assist with appointment communication, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support for an in-person hospital visit. This pre-travel pathway helps patients prepare the clinical documents and practical logistics before committing to travel.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Zhilong Ai
Areas of Expertise
Thyroid diseases (including thyroid nodules, thyroid cancer, papillary thyroid cancer, and thyroid adenoma)
Parathyroid diseases
Neck masses and related conditions
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
30,100 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Director, Surgical Day Ward Department, Zhongshan Hospital
Deputy Administrative Director, Department of General Surgery, Zhongshan Hospital
General Surgery, Zhongshan Hospital, Fudan University
General Surgery, Shanghai Xuhui District Central Hospital
Education & Training
Graduated from the former Shanghai Medical University, majoring in Clinical Medicine
Awards & Honors
"Shanghai Municipal New Long March Shock Worker" (1995)
First Prize, "Middle-aged and Young Doctor Paper Competition," Surgical Branch, Shanghai Medical Association (2007)
Academic & Professional Memberships
National Committee Member, Thyroid and Metabolic Surgery Group, Surgical Branch, Chinese Medical Association
National Committee Member, Thyroid Cancer Professional Committee, Chinese Anti-Cancer Association (CACA)
National Committee Member, Thyroid Disease Professional Committee, China International Exchange and Promotive Association for Medical and Health Care (CPAM)
National Standing Committee Member, Perioperative Care Group, Thyroid Disease Professional Committee, Chinese Research Hospital Association (CRHA)
National Committee Member, Bone Metabolism and Parathyroid Disease Professional Committee, Chinese Research Hospital Association (CRHA)
Committee Member, Thyroid Surgery Group, Surgical Branch, Shanghai Medical Association
Committee Member, Thyroid Cancer Professional Committee, Shanghai Anti-Cancer Association
Research & Publications
Undertook one general project funded by the National Natural Science Foundation of China (NSFC)
Published 10 SCI-indexed papers as the first author
Contributed to the editing of the latest edition of "Practical Surgery"
Selected Peer-Reviewed Publications
Zhao J, et al. Safety and effectiveness of carbon nanoparticles suspension-guided lymph node dissection during thyroidectomy in patients with thyroid papillary cancer: a prospective, multicenter, randomized, blank-controlled trial. Front Endocrinol (Lausanne). 2024;14:1251820. PMID: 38260138.
Liu W, et al. Clinical performance of a machine learning-based model for detecting lymph node metastasis in papillary thyroid carcinoma: a multicenter study. Int J Surg. 2025;111(6):4062-4067. PMID: 40265473.
Zhu W, Zhong M, Ai Z. Systematic evaluation of prophylactic neck dissection for the treatment of papillary thyroid carcinoma. Jpn J Clin Oncol. 2013;43(9):883-888. PMID: 23858039.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Ai's clinical expertise relevant to my thyroid or parathyroid condition?
Dr. Ai's documented clinical focus includes thyroid nodules, thyroid adenoma, thyroid cancer, papillary thyroid cancer, parathyroid disease, and neck masses. International patients can request MedBridgeNZ coordination for a remote specialist-review pathway. Once Zhongshan Hospital confirms the arrangement, Dr. Ai will review the submitted medical records, imaging, and diagnostic reports, provide a specialist opinion and recommendations, and respond to the questions included with the case. This pre-travel review can help clarify whether an in-person hospital pathway in Shanghai should be considered and what information may be needed next.
How can international patients request a remote specialist review with Dr. Ai?
MedBridgeNZ coordinates the administrative steps for international patients, including record organization, translation coordination where needed, secure client-authorized document transfer, and communication with Zhongshan Hospital regarding the review request. Once the hospital accepts and schedules the pathway, the submitted materials will be reviewed by Dr. Ai and the specialist response will be returned through the arranged communication channel. MedBridgeNZ does not make medical judgments or alter the specialist's opinion; our role is to keep the records, communication, and logistics organized.
What happens after Dr. Ai provides the remote specialist opinion?
After Dr. Ai's opinion and recommendations are received, the patient can decide whether to pursue an in-person evaluation in Shanghai. Where an onsite pathway is requested, MedBridgeNZ can assist with hospital appointment communication, medical invitation or visa-document coordination support, travel planning, translation coordination, and non-clinical bilingual administrative support during the hospital visit. Appointment timing and the final clinical plan are determined by Zhongshan Hospital and the treating team, while the pre-travel review gives patients a clearer basis for preparing records, questions, timing, and practical travel arrangements.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, secure client-authorized document transfer, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis, or treatment; all clinical opinions and decisions are provided independently by licensed specialists and hospitals. MedBridgeNZ service fees cover the coordination services stated in writing, while hospital, specialist, and other third-party costs remain separate unless expressly included in a written quotation.